Market Overview:
The global COPD and asthma drug devices market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing prevalence of COPD and asthma, rising geriatric population, and technological advancements in drug delivery devices. Based on type, the COPD & asthma inhaler segment accounted for the largest share of the global COPD and asthma drug devices market in 2017. This segment is expected to grow at a CAGR of 6.1% from 2018 to 2030 due to the increasing demand for metered dose inhalers (MDIs) and dry powder inhalers (DPIs). Based on application, hospitals accounted for the largest share of the global COPD and asthma drug devices market in 2017.
Product Definition:
COPD and asthma drug devices are used to treat respiratory conditions. They help to open the airways and improve breathing.
COPD & Asthma Inhaler:
COPD & Asthma inhaler, also called asthma inhaler or asthmatic inhaler, is a device used to alleviate the symptoms of Chronic Obstructive Pulmonary Disease (COPD) and asthma. The drug delivery system in an asthma inhaler is different from that in a COPD spray as it contains medication for only one of the conditions.
COPD & Asthma Nebulizer:
COPD & asthma nebulizer is a portable device used to dispense medication and oxygen in chronic obstructive pulmonary disease (COPD) and asthma. The COPD & Asthma Nebulizer consists of an airway pressure monitor, a compressor, an expiratory valve, and a therapy tank. It is mainly used for the treatment of bronchospasm or emphysema due to either acute or chronic exposure.
Application Insights:
Based on application, the global COPD and asthma drug devices market is segmented into hospitals, clinics and other facilities. The hospital segment dominated the market in 2017 owing to factors such as a large patient base with chronic respiratory diseases and an increasing number of hospitals across the globe. In addition, a rising number of research studies conducted in major countries such as India regarding new device approvals for COPD/asthma treatment will also boost industry growth over the forecast period.
The others segment includes home healthcare services, pharmacies and other retail outlets that offer inhalers for sale or rental under various brand names. Increasing awareness about asthma among patients suffering from allergies has led to an increased demand for portable inhalers that can be used at home without medical assistance or supervision; this trend is expected to drive industry growth over the forecast period due to increasing product adoption by consumers globally.
Regional Analysis:
North America dominated the global COPD and asthma drug devices market in 2017. This can be attributed to the presence of key players, high awareness levels about asthma treatment options, well-established healthcare infrastructure and availability of reimbursement coverage for medical treatments. In addition, increasing government initiatives to control this disease is also expected to contribute toward market growth over the forecast period. For instance, as part of its efforts towards reducing mortality rate associated with COPD by 50% by 2020 and prevalence rates through increased education about diagnosis & management strategies for this condition are some of the initiatives taken by National Heart Lung and Blood Institute (NHLBI).
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to an increase in demand for better treatment facilities coupled with rising disposable income especially in developing countries such as India & China. Moreover, growing target population base due to rapid urbanization will further boost revenue generation from this region during 2018 - 2030 time frame.
Growth Factors:
- Increasing prevalence of COPD and asthma
- Growing awareness about the available treatment options for COPD and asthma
- Rising demand for novel drug delivery devices for the treatment of COPD and asthma
- Technological advancements in the field of drug delivery devices for COPD and asthma treatment
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
COPD and Asthma Drug Devices Market Research Report
By Type
COPD & Asthma Inhaler, COPD & Asthma Nebulizer
By Application
Hospitals, Clinics, Others
By Companies
Novartis International AG, Merck, AstraZeneca, GlaxoSmithKline, 3M Healthcare, GF Health Products, Inc, Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International, Koninklijke Philips N.V., Novartis International AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
140
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global COPD and Asthma Drug Devices Market Report Segments:
The global COPD and Asthma Drug Devices market is segmented on the basis of:
Types
COPD & Asthma Inhaler, COPD & Asthma Nebulizer
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis International AG
- Merck
- AstraZeneca
- GlaxoSmithKline
- 3M Healthcare
- GF Health Products, Inc
- Sunovion Pharmaceuticals Inc.
- Smith Medicals, Inc.
- Baxter International
- Koninklijke Philips N.V.
- Novartis International AG
Highlights of The COPD and Asthma Drug Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- COPD & Asthma Inhaler
- COPD & Asthma Nebulizer
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the COPD and Asthma Drug Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
COPD and asthma drug devices are medical devices that help people with these conditions breathe better. COPD is a condition in which the airways become inflamed and narrowed, making it difficult to breathe. Asthma is a chronic lung disease that causes shortness of breath, chest tightness, coughing, and wheezing. Drug devices can be used to treat both COPD and asthma by helping people take their medications more regularly or by providing relief from symptoms.
Some of the major companies in the copd and asthma drug devices market are Novartis International AG, Merck, AstraZeneca, GlaxoSmithKline, 3M Healthcare, GF Health Products, Inc, Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International, Koninklijke Philips N.V., Novartis International AG.
The copd and asthma drug devices market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 COPD and Asthma Drug Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 COPD and Asthma Drug Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 COPD and Asthma Drug Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the COPD and Asthma Drug Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global COPD and Asthma Drug Devices Market Size & Forecast, 2018-2028
4.5.1 COPD and Asthma Drug Devices Market Size and Y-o-Y Growth
4.5.2 COPD and Asthma Drug Devices Market Absolute $ Opportunity
Chapter 5 Global COPD and Asthma Drug Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 COPD and Asthma Drug Devices Market Size Forecast by Type
5.2.1 COPD & Asthma Inhaler
5.2.2 COPD & Asthma Nebulizer
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global COPD and Asthma Drug Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 COPD and Asthma Drug Devices Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global COPD and Asthma Drug Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 COPD and Asthma Drug Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America COPD and Asthma Drug Devices Analysis and Forecast
9.1 Introduction
9.2 North America COPD and Asthma Drug Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America COPD and Asthma Drug Devices Market Size Forecast by Type
9.6.1 COPD & Asthma Inhaler
9.6.2 COPD & Asthma Nebulizer
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America COPD and Asthma Drug Devices Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe COPD and Asthma Drug Devices Analysis and Forecast
10.1 Introduction
10.2 Europe COPD and Asthma Drug Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe COPD and Asthma Drug Devices Market Size Forecast by Type
10.6.1 COPD & Asthma Inhaler
10.6.2 COPD & Asthma Nebulizer
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe COPD and Asthma Drug Devices Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific COPD and Asthma Drug Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific COPD and Asthma Drug Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific COPD and Asthma Drug Devices Market Size Forecast by Type
11.6.1 COPD & Asthma Inhaler
11.6.2 COPD & Asthma Nebulizer
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific COPD and Asthma Drug Devices Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America COPD and Asthma Drug Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America COPD and Asthma Drug Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America COPD and Asthma Drug Devices Market Size Forecast by Type
12.6.1 COPD & Asthma Inhaler
12.6.2 COPD & Asthma Nebulizer
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America COPD and Asthma Drug Devices Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) COPD and Asthma Drug Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) COPD and Asthma Drug Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) COPD and Asthma Drug Devices Market Size Forecast by Type
13.6.1 COPD & Asthma Inhaler
13.6.2 COPD & Asthma Nebulizer
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) COPD and Asthma Drug Devices Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 COPD and Asthma Drug Devices Market: Competitive Dashboard
14.2 Global COPD and Asthma Drug Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis International AG
14.3.2 Merck
14.3.3 AstraZeneca
14.3.4 GlaxoSmithKline
14.3.5 3M Healthcare
14.3.6 GF Health Products, Inc
14.3.7 Sunovion Pharmaceuticals Inc.
14.3.8 Smith Medicals, Inc.
14.3.9 Baxter International
14.3.10 Koninklijke Philips N.V.
14.3.11 Novartis International AG
